{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:30:47Z","timestamp":1773286247881,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.dsx.2013.02.015","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T00:36:55Z","timestamp":1362789415000},"page":"32-34","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of vildagliptin on glucose fluctuation in Japanese type 2 diabetic patients with ongoing sulfonylurea based oral glycemic agent therapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Keiji","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Isotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichiro","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2013.02.015_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8227(01)00282-0","article-title":"Characteristics of type 2 diabetic patients responding to voglibose administration as an adjunct to sulfonylurea","volume":"54","author":"Hirose","year":"2001","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.dsx.2013.02.015_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/092986706789803035","article-title":"(Basen, AO-128), one of the most important alpha-glucosidase inhibitors","volume":"13","author":"Chen","year":"2006","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.dsx.2013.02.015_bib0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.metabol.2004.10.004","article-title":"Effect of two alpha-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms","volume":"54","author":"Fujisawa","year":"2005","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.1016\/j.dsx.2013.02.015_bib0020","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF03346357","article-title":"Dipepdyl peptidase 4 (DDP-4) inhibitors and their role in Type 2 diabetes management","volume":"30","author":"Crepaldi","year":"2007","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.dsx.2013.02.015_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-2999(00)00600-2","article-title":"Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice","volume":"404","author":"Ahren","year":"2000","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.dsx.2013.02.015_bib0030","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/diabetes.50.7.1588","article-title":"Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs","volume":"50","author":"Deacon","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2013.02.015_bib0035","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1463-1326.2010.01222.x","article-title":"Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active controlled study","volume":"12","author":"Iwamoto","year":"2010","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.dsx.2013.02.015_bib0040","unstructured":"Takahara M, Shiraiwa T, Kaneto H, Katakami N, Matsuoka T, Shimomura I. Efficacy of sitagliptin on blood glucose fluctuation in Japanese type 2 diabetic patients with basal-supported oral therapy. EJ12-0220. EJ http:\/\/dx.doi.org\/10.1507\/endocrj."},{"key":"10.1016\/j.dsx.2013.02.015_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.0954-6820.1965.tb01810.x","article-title":"The M-value, an index of blood sugar control in diabetics","volume":"177","author":"Schlichtkrull","year":"1965","journal-title":"Acta Medica Scandinavica"},{"key":"10.1016\/j.dsx.2013.02.015_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2007-979906","article-title":"\u201cJ\u201d-index. A new proposition of the assessment of current glucose control in diabetic patients","volume":"27","author":"W\u00f3jcicki","year":"1995","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.dsx.2013.02.015_bib0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","author":"Seino","year":"2010","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.dsx.2013.02.015_bib0060","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.dsx.2013.02.015_bib0065","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s001250100020","article-title":"Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes","volume":"44","author":"Bonora","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2013.02.015_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.54.1.1","article-title":"Postprandial hyperglycemia and diabetic complications: is it time to treat?","volume":"54","author":"Ceriello","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2013.02.015_bib0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-2007-979065","article-title":"The efficacy of voglibose on daily glycemic excursions assessed by the \u201cJ\u201d-index in non-insulin dependent diabetes mellitus","volume":"29","author":"Yoshioka","year":"1997","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.dsx.2013.02.015_bib0080","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2337\/diacare.20.3.462a","article-title":"Rapid improvement of serum 1,5-anhydorglucitol concentration of \u03b1-glucosidase inhibitor","volume":"20","author":"Yoshioka","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2013.02.015_bib0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-2007-970422","article-title":"Vildagliptin in drug-na\u00efve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose study","volume":"39","author":"Dejager","year":"2007","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.dsx.2013.02.015_bib0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1463-1326.2009.01187.x","article-title":"Efficacy and safety of monotherapy sitagliptin compared with metformin in patients with type 2 diabetes","volume":"12","author":"Aschner","year":"2010","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.dsx.2013.02.015_bib0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4093\/dmj.2011.35.4.411","article-title":"Efficacy of sitagliptin when added to ongoing therapy in Korean subjects with type 2 diabetes mellitus","volume":"35","author":"Chung","year":"2011","journal-title":"Diabetes & Metabolism Journal"},{"key":"10.1016\/j.dsx.2013.02.015_bib0100","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1136\/bmj.e1369","article-title":"Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systemic review and meta-analysis","volume":"344","author":"Karagiannis","year":"2012","journal-title":"British Medical Journal"},{"key":"10.1016\/j.dsx.2013.02.015_bib0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1475-2840-11-92","article-title":"Comparison of vildagliptin vs. sitagliptin one daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study)","volume":"11","author":"Sakamoto","year":"2012","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.dsx.2013.02.015_bib0110","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2337\/dc12-0199","article-title":"Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibitor","volume":"35","author":"Rizzo","year":"2012","journal-title":"Diabetes Care"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402113000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402113000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T01:24:58Z","timestamp":1539825898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402113000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1871402113000167"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2013.02.015","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}